Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21209444rdf:typepubmed:Citationlld:pubmed
pubmed-article:21209444lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:21209444lifeskim:mentionsumls-concept:C1629505lld:lifeskim
pubmed-article:21209444lifeskim:mentionsumls-concept:C0441994lld:lifeskim
pubmed-article:21209444lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:21209444lifeskim:mentionsumls-concept:C0814514lld:lifeskim
pubmed-article:21209444lifeskim:mentionsumls-concept:C0010186lld:lifeskim
pubmed-article:21209444lifeskim:mentionsumls-concept:C0181586lld:lifeskim
pubmed-article:21209444lifeskim:mentionsumls-concept:C0220812lld:lifeskim
pubmed-article:21209444lifeskim:mentionsumls-concept:C0680968lld:lifeskim
pubmed-article:21209444pubmed:issue1lld:pubmed
pubmed-article:21209444pubmed:dateCreated2011-1-6lld:pubmed
pubmed-article:21209444pubmed:abstractTextResearchers have routinely found that improved medication adherence--getting people to take medicine prescribed for them--is associated with greatly reduced total health care use and costs. But previous studies do not provide strong evidence of a causal link. This article employs a more robust methodology to examine the relationship. Our results indicate that although improved medication adherence by people with four chronic vascular diseases increased pharmacy costs, it also produced substantial medical savings as a result of reductions in hospitalization and emergency department use. Our findings indicate that programs to improve medication adherence are worth consideration by insurers, government payers, and patients, as long as intervention costs do not exceed the estimated health care cost savings.lld:pubmed
pubmed-article:21209444pubmed:languageenglld:pubmed
pubmed-article:21209444pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21209444pubmed:citationSubsetIMlld:pubmed
pubmed-article:21209444pubmed:statusMEDLINElld:pubmed
pubmed-article:21209444pubmed:monthJanlld:pubmed
pubmed-article:21209444pubmed:issn1544-5208lld:pubmed
pubmed-article:21209444pubmed:authorpubmed-author:BrennanTroyen...lld:pubmed
pubmed-article:21209444pubmed:authorpubmed-author:LibermanJoshu...lld:pubmed
pubmed-article:21209444pubmed:authorpubmed-author:RoebuckM...lld:pubmed
pubmed-article:21209444pubmed:authorpubmed-author:Gemmill-Toyam...lld:pubmed
pubmed-article:21209444pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21209444pubmed:volume30lld:pubmed
pubmed-article:21209444pubmed:ownerNLMlld:pubmed
pubmed-article:21209444pubmed:authorsCompleteYlld:pubmed
pubmed-article:21209444pubmed:pagination91-9lld:pubmed
pubmed-article:21209444pubmed:meshHeadingpubmed-meshheading:21209444...lld:pubmed
pubmed-article:21209444pubmed:meshHeadingpubmed-meshheading:21209444...lld:pubmed
pubmed-article:21209444pubmed:meshHeadingpubmed-meshheading:21209444...lld:pubmed
pubmed-article:21209444pubmed:meshHeadingpubmed-meshheading:21209444...lld:pubmed
pubmed-article:21209444pubmed:meshHeadingpubmed-meshheading:21209444...lld:pubmed
pubmed-article:21209444pubmed:meshHeadingpubmed-meshheading:21209444...lld:pubmed
pubmed-article:21209444pubmed:meshHeadingpubmed-meshheading:21209444...lld:pubmed
pubmed-article:21209444pubmed:meshHeadingpubmed-meshheading:21209444...lld:pubmed
pubmed-article:21209444pubmed:meshHeadingpubmed-meshheading:21209444...lld:pubmed
pubmed-article:21209444pubmed:meshHeadingpubmed-meshheading:21209444...lld:pubmed
pubmed-article:21209444pubmed:year2011lld:pubmed
pubmed-article:21209444pubmed:articleTitleMedication adherence leads to lower health care use and costs despite increased drug spending.lld:pubmed
pubmed-article:21209444pubmed:affiliationCVS Caremark, Hunt Valley, Maryland, USA. chris.roebuck@caremark.comlld:pubmed
pubmed-article:21209444pubmed:publicationTypeJournal Articlelld:pubmed